Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2023 | Outcomes following FD & NFD related donor haplo transplantation for patients with acute leukemias

Norbert-Claude Gorin • 23 Apr 2023
EBMT 2023
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia

Norbert-Claude Gorin, MD, PhD, Saint-Antoine Hospital and Sorbonne University, Paris, France, outlines the results of a study evaluating the outcomes of patients with acute leukemias in complete remission who received first-degree and non-first-degree related donor haploidentical transplantation. Overall, the study showed that outcomes were similar between both groups. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Norbert-Claude Gorin

1:33
The impact of novel targeted & immune therapies in leukemia
Norbert-Claude Gorin • 23 Apr 2023
1:08
The progress of the EBMT & key ongoing projects
Norbert-Claude Gorin • 23 Apr 2023
1:23
Indications for autologous stem cell transplantation in AML
Norbert-Claude Gorin • 23 Apr 2023
1:39
The evolution of stem cell transplantation
Norbert-Claude Gorin • 23 Apr 2023

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals